StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Johnson & Johnson
NYSE:JNJ
Sector
Location
Market Cap
USD 393.87 B
Share Price
USD 163.70
Avg Daily Volume
8,376,966
Change (1 day)
0.44%
Change (1 year)
5.33%
Change (YTD)
13.19%
Johnson & Johnson EBIT Margin for the Trailing 12 Months (TTM) ending March 30, 2025: 30.68%
Johnson & Johnson EBIT Margin is 30.68% for the Trailing 12 Months (TTM) ending March 30, 2025, a 26.47% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Johnson & Johnson EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 24.26%, a 49.25% change year over year.
-
Johnson & Johnson EBIT Margin for the Trailing 12 Months (TTM) ending April 02, 2023 was 16.25%, a -27.73% change year over year.
-
Johnson & Johnson EBIT Margin for the Trailing 12 Months (TTM) ending April 03, 2022 was 22.49%, a 7.27% change year over year.
-
Johnson & Johnson EBIT Margin for the Trailing 12 Months (TTM) ending April 04, 2021 was 20.97%, a -11.76% change year over year.
Competitors
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.71
600436.SS
+0.12
0.42%
Yunnan Baiyao Group Co.,Ltd
USD 7.83
000538.SZ
+0.00
0.03%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Ajanta Pharma Limited
USD 32.18
AJANTPHARM.NS
-0.19
-0.58%
Jamjoom Pharmaceuticals Factory Company
USD 46.96
4015.SR
+0.56
1.20%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.12
-0.88%
Gerresheimer AG
USD 54.80
GXI.DE
+0.07
0.13%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.64
600572.SS
+0.00
0.23%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.71
600436.SS
+0.12
0.42%
Yunnan Baiyao Group Co.,Ltd
USD 7.83
000538.SZ
+0.00
0.03%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Ajanta Pharma Limited
USD 32.18
AJANTPHARM.NS
-0.19
-0.58%
Jamjoom Pharmaceuticals Factory Company
USD 46.96
4015.SR
+0.56
1.20%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.12
-0.88%
Gerresheimer AG
USD 54.80
GXI.DE
+0.07
0.13%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.64
600572.SS
+0.00
0.23%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%